ASH Updates on cHL: 2L Pembro + GVD, Brentuximab Vedotin & Checkpoint Blockade Combination in High Risk Patients

108 views
March 5, 2021
0 Comments
Login to view comments. Click here to Login
6th Annual Updates from ASH 2020